Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil

被引:16
作者
Aczél, S [1 ]
Kurka, B [1 ]
Hering, S [1 ]
机构
[1] Inst Biochem Pharmacol, A-6020 Innsbruck, Austria
关键词
Ca2+ channels; mibefradil; use-dependent block; open state block; calcium channel inactivation;
D O I
10.1038/sj.bjp.0702092
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The action of mibefradil was studied on wild type class A calcium (Ca2+) channels and various class A/L-type channel chimaeras expressed in Xenopus oocytes. The mechanism of Ca2+ channel block by mibefradil was evaluated with two microelectrode voltage clamp. 2 Resting-state dependent block (or initial block) of barium currents (I-Ba) through class A Ca2+ channels was concentration dependent with an IC50 value of 208+/-23 mu M. 3 Mibefradil (50 mu M) did not significantly affect the midpoint voltage of the steady-state inactivation curve suggesting that inactivation does not promote Ca2+ channel block. Chimaeric class A/L-type Ca2+ channels inactivating with faster or slower kinetics than wild type class A channels were equally well inhibited by mibefradil as wild type class A channels. 4 Frequent Ca2+ channel activation facilitated I-Ba inhibition by mibefradil (use-dependent block). Recovery from use-dependent block was voltage-dependent. being slower at depolarized membrane potentials (tau = 75 +/- 15 s at -70 mV, (n = 6) vs tau = 20 +/- 2 s at - 100 mV, (n = 6), P<0.05). 5 We suggest that use-dependent block of class A Ca2+ channels by mibefradil occurs because of slow recovery from open channel block (SROB) and not because of drug binding to inactivated channels. 6 Voltage-dependent slow recovery from open state-dependent block provides a molecular basis for understanding the cardiovascular profile of mibefradil such as selectivity for vasculature and relative lack of negative inotropic effects.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 31 条
[1]   Extra- and intracellular action of quaternary devapamil on muscle L-type Ca2+-channels [J].
Berjukov, S ;
Aczel, S ;
Beyer, B ;
Kimball, SD ;
Dichtl, M ;
Hering, S ;
Striessnig, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) :1197-1202
[2]   Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967) - A new generation of calcium antagonists? [J].
Bernink, PJLM ;
Prager, G ;
Schelling, A ;
Kobrin, I .
HYPERTENSION, 1996, 27 (03) :426-432
[3]  
BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540
[4]   Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: A multicenter placebo-controlled study [J].
Braun, S ;
vanderWall, EE ;
Emanuelsson, H ;
Kobrin, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) :317-322
[5]   EFFECTS OF RO-40-5967, A NOVEL CALCIUM-ANTAGONIST, ON MYOCARDIAL-FUNCTION DURING ISCHEMIA INDUCED BY LOWERING CORONARY PERFUSION-PRESSURE IN DOGS - COMPARISON WITH VERAPAMIL [J].
CLOZEL, JP ;
BANKEN, L ;
OSTERRIEDER, W .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (05) :713-721
[6]   Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site [J].
Degtiar, VE ;
Aczel, S ;
Doring, F ;
Timin, EN ;
Berjukow, S ;
Kimball, D ;
Mitterdorfer, J ;
Hering, S .
BIOPHYSICAL JOURNAL, 1997, 73 (01) :157-167
[7]   Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha(1A) [J].
Doring, F ;
Degtiar, VE ;
Grabner, M ;
Striessnig, J ;
Hering, S ;
Glossmann, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) :11745-11749
[8]   SEQUENCE AND EXPRESSION OF MESSENGER-RNAS ENCODING THE ALPHA-1-SUBUNIT AND ALPHA-2-SUBUNIT OF A DHP-SENSITIVE CALCIUM-CHANNEL [J].
ELLIS, SB ;
WILLIAMS, ME ;
WAYS, NR ;
BRENNER, R ;
SHARP, AH ;
LEUNG, AT ;
CAMPBELL, KP ;
MCKENNA, E ;
KOCH, WJ ;
HUI, A ;
SCHWARTZ, A ;
HARPOLD, MM .
SCIENCE, 1988, 241 (4873) :1661-1664
[9]  
FANG LM, 1991, EUR J PHARMACOL, V196, P205
[10]   Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels [J].
Grabner, M ;
Wang, ZY ;
Hering, S ;
Striessnig, J ;
Glossmann, H .
NEURON, 1996, 16 (01) :207-218